Search Results

Substitution of Immediate-Release Valproic Acid for Divalproex Sodium for Adult Psychiatric Inpatients

• Authors : Sherr, Jay D.; Kelly, Deanna L.

• Source: Psychiatric Services; Oct1998, Vol. 49 Issue 10, p1355, 3p

Record details

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

• Authors : Kelly, Deanna L.; Nelson, Matthew W.; Love, Raymond C.

• Source: Psychiatric Services; May2001, Vol. 52 Issue 5, p676-678, 3p

Record details

Treatment of the special patient with schizophrenia

• Authors : Conley, Robert R.; Kelly, Deanna L.

• Source: Dialogues in Clinical Neuroscience; June 2001, Vol. 3 Issue: 2 p123-135, 13p

Record details

Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations.

• Authors : Kelly, Deanna L.; Love, Raymond C.

• Source: Psychopharmacology Bulletin; Autumn2001, Vol. 35 Issue 4, p66-79, 14p

Record details

In Reply: Conclusions About Risperidone.

• Authors : Kelly, Deanna L.; Nelson, Matthew W.; Love, Raymond C.

• Source: Psychiatric Services; Nov2001, Vol. 52 Issue 11, p1535-1535, 2/3p

Record details

Current status of antipsychotic treatment.

• Authors : Conley RR; University of Maryland, Maryland Psychiatric Research Center, Baltimore, MD 21228, USA. ; Kelly DL

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Schizophrenia/Schizophrenia/Schizophrenia/*drug therapy; Animals

• Source: Current drug targets. CNS and neurological disorders [Curr Drug Targets CNS Neurol Disord] 2002 Apr; Vol. 1 (2), pp. 123-8.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101151150 Publication Model: Print Cited Medium: Print ISSN:

Record details

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

• Authors : McMahon RP; Department of Psychiatry, Maryland Psychiatric Research Center, Spring Grove Hospital Grounds, Maple and Locust Avenues, PO Box 21247, Baltimore, MD 21228, USA. ; Kelly DL

Subjects: Psychiatric Status Rating Scales* ; Schizophrenic Psychology*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use

• Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2002 Apr; Vol. 26 (4), pp. 537-45.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print Cited Medium: Print ISSN: 0893-133X

Record details

Circumstances of suicide among individuals with schizophrenia.

• Authors : Kreyenbuhl JA; Maryland Psychiatric Research Center, University of Maryland, PO Box 21247, Baltimore, MD 21228, USA.; Kelly DL

Subjects: Life Change Events*; Depression/Depression/Depression/*epidemiology ; Schizophrenia/Schizophrenia/Schizophrenia/*epidemiology

• Source: Schizophrenia research [Schizophr Res] 2002 Dec 01; Vol. 58 (2-3), pp. 253-61.Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print Cited Medium: Print ISSN:

Record details

Rehospitalization risk with second-generation and depot antipsychotics.

• Authors : Conley RR; Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA. ; Kelly DL

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*administration & dosage ; Fluphenazine/Fluphenazine/Fluphenazine/*analogs & derivatives ; Patient Readmission/Patient Readmission/Patient Readmission/*statistics & numerical data

• Source: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists [Ann Clin Psychiatry] 2003 Mar; Vol. 15 (1), pp. 23-31.Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 8911021 Publication Model: Print Cited Medium: Print ISSN:

Record details

Clozapine treatment in patients with prior substance abuse.

• Authors : Kelly DL; School of Medicine, University of Maryland, Baltimore, Maryland, USA. ; Gale EA

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Clozapine/Clozapine/Clozapine/*therapeutic use ; Schizophrenia/Schizophrenia/Schizophrenia/*complications

• Source: Canadian journal of psychiatry. Revue canadienne de psychiatrie [Can J Psychiatry] 2003 Mar; Vol. 48 (2), pp. 111-4.Publisher: Sage Country of Publication: United States NLM ID: 7904187 Publication Model: Print Cited Medium: Print ISSN: 0706-7437 (Print)

Record details